A comprehensive investigation of the anion inhibition profile of a β-carbonic anhydrase from Acinetobacter baumannii for crafting innovative antimicrobial treatments
This study refers to the intricate world of Acinetobacter baumannii, a resilient pathogenic bacterium notorious for its propensity at antibiotic resistance in nosocomial infections. Expanding upon previous findings that emphasised the bifunctional enzyme PaaY, revealing unexpected γ-carbonic anhydrase (CA) activity, our research focuses on a different class of CA identified within the A. baumannii genome, the β-CA, designated as 𝛽-AbauCA (also indicated as CanB), which plays a crucial role in the resistance mechanism mediated by AmpC beta-lactamase. Here, we cloned, expressed, and purified the recombinant 𝛽-AbauCA, unveiling its distinctive kinetic properties and inhibition profile with inorganic anions (classical CA inhibitors). The exploration of 𝛽-AbauCA not only enhances our understanding of the CA repertoire of A. baumannii but also establishes a foundation for targeted therapeutic interventions against this resilient pathogen, promising advancements in combating its adaptability and antibiotic resistance.
展开▼
机译:这项研究提到了鲍曼不动杆菌的错综复杂的世界,鲍曼不动杆菌是一种顽强的病原菌,因其在医院感染中表现出抗生素耐药性的倾向而臭名昭著。扩展了先前强调双功能酶 PaaY 的发现,揭示了意想不到的 γ-碳酸酐酶 (CA) 活性,我们的研究重点是在鲍曼不动杆菌基因组中鉴定的另一类 CA,即 β-CA,命名为 β-AbauCA(也称为 CanB),它在 AmpC β-内酰胺酶介导的耐药机制中起着至关重要的作用。在这里,我们克隆、表达和纯化了重组 β-AbauCA,揭示了其独特的动力学特性和对无机阴离子(经典 CA 抑制剂)的抑制特性。β-AbauCA 的探索不仅增强了我们对鲍曼不动杆菌 CA 库的理解,而且还为针对这种弹性病原体的靶向治疗干预奠定了基础,有望在对抗其适应性和抗生素耐药性方面取得进展。
展开▼